T1	Participants 50 64	ovarian cancer
T2	Participants 441 481	Women with newly-diagnosed epithelial OC
T3	Participants 398 417	ovarian cancer (OC)
T4	Participants 1061 1119	Seventy-seven women were evaluable for the primary outcome
T6	Participants 501 535	receive standard chemotherapy (CT)
T5	Participants 1615 1667	women receiving CT for newly-diagnosed epithelial OC
